Error loading player: No playable sources found
67376
Session III: Gene Therapies and New Modalities Part II
Date
September 26, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Gene Therapies and New Modalities Part II
Session Speakers:
High Throughput LabChip Purity Assessment Method for Gene Delivery Vehicles
Anubhav Tripathi, Brown University
Nucleic Acid Analysis by Capillary Gel Electrophoresis (CGE): Developing and Implementing a Multivalent Analytical Assay to Characterize and Control In-Process Mixtures of Cell Therapy Products
Brian Roper, Genentech
Development, Qualification and Understanding Spike Protein in COVID-19 Vaccine using Capillary Western Technology
Paul Gillespie, Merck & Co., Inc.
Discussion: 9:45 - 10:00
Session Speakers:
High Throughput LabChip Purity Assessment Method for Gene Delivery Vehicles
Anubhav Tripathi, Brown University
Nucleic Acid Analysis by Capillary Gel Electrophoresis (CGE): Developing and Implementing a Multivalent Analytical Assay to Characterize and Control In-Process Mixtures of Cell Therapy Products
Brian Roper, Genentech
Development, Qualification and Understanding Spike Protein in COVID-19 Vaccine using Capillary Western Technology
Paul Gillespie, Merck & Co., Inc.
Discussion: 9:45 - 10:00
Session Chairs
Related Products
Spotlight Talk
Single-Run Separation and Quantification of 14 Cannabinoids Using Capillary Electrophoresis
Session II: Gene Therapies and New Modalities Part I
Development of an icIEF Assay for Monitoring AAV Capsid Proteins and Application to Gene Therapy Products
Partner Showcase III
The following vendor partners will each present a 5-minute presentation on their company's products and services. Join to learn more about our exhibitors and how they can help better serve you and your customers…
Troubleshooting Workshop
Session Speaker:
